(Fort Worth, TX) --- H. Paul Dorman, Chairman and Chief Executive Officer of Fort Worth-based DFB Pharmaceuticals, Inc., has announced that Travis E. Baugh has joined HEALTHPOINT®, Ltd., a DFB Pharmaceuticals company, as President and Chief Operating Officer.

    “ Travis comes to Healthpoint with a distinguished career as a global operations and financial executive in a variety of industries, including medical devices, oil and gas services, industrial retail and international publishing,” said Mr. Dorman. “Over the years, he has served on the boards of several companies and brings to Healthpoint a deep expertise in running successful organizations.”

    A seasoned executive and a member of the DFB Pharmaceuticals board of directors since 2004, Mr. Baugh brings to Healthpoint almost three decades of public and private company leadership experience. Mr. Baugh was most recently president and CEO of LifeCap Resources, LLC, a consulting firm for venture capital groups and early-stage science companies. Prior to founding LifeCap in 2007, Mr. Baugh was CEO of MicroMed Cardiovascular, Inc., a medical device manufacturing company that developed the DeBakey VAD®, a miniaturized ventricular assist device (heart pump) developed in collaboration with NASA and Dr. Michael DeBakey and his team at the Baylor College of Medicine. In the company’s early stages, Mr. Baugh raised venture capital and bank financing and led the company through the process of becoming a public company in 2005. In the early 1990’s, Mr. Baugh was senior vice president of finance and operations and CFO for Grasso Corporation (NASDAQ: GRSO), a publicly traded oil service company.

    Mr. Baugh also serves on the board of Biophan Technologies (OTC BB:BIPH.OB). He is a Certified Public Accountant and is currently licensed in New York and Texas.

    Since its inception in 1992, Fort Worth, Texas-based Healthpoint has established a U.S. presence in the research, development, and marketing of branded pharmaceuticals, over the counter drugs, and medical devices for tissue management and surgical indications. An aggressive research and development effort has brought Healthpoint’s unique technologies to the market, setting the pace for its highly trained field sales organization of direct sales representatives. Healthpoint, with 270 employees, is a DFB Pharmaceuticals, Inc. affiliate. Visit Healthpoint’s Web site: www.healthpoint.com.